Table 5.
Subjects | N | Intervention | Findings | Reference |
---|---|---|---|---|
Animals | ||||
Female Balb/c mice, 7 wk and 19 mo | 8/10 (C) 8/10 (PB) |
Live L. bulgaricus +S.thermophilus (4x108 CFUs, each) for 7 d |
|
Muscettola et al. 1994 [152] |
Balb/c mice, 6 wk | 5 (C) 5x6 (PB) |
Live W. kimchii, L. fermentum, L. plantarum (107 CFUs/d, each or 109 CFUs/d, each) for 3 wk |
|
Lee and Lee, 2005 [163] |
Male C57BL/6 mice, 20 mo | Complete 6 (C) 6 (PB) Low protein 8 (C) 8 (PB) |
L. johnsonii La1 (≥1x109 CFUs/d) for 14 d |
In complete diet
|
Kaburagi et al. 2007 [161] |
Balb/c mice, 6–8 wk | 6 (C) 6x6 (PB) |
L. paracasei subsp. paracasei NTU 101 (108 CFUs/d) for 3, 6, 9 wk |
|
Tsai et al. 2008 [164] |
Male C57BL/6 mice, 21 mo | 10 (C) 15 (PB) 15 (S) |
PB: L. paracasei NCC2461 (1x109 CFUs/d) S: L. paracasei NCC2461 (1x109 CFUs/d) + fructo-oligosaccharide+inulin, given in the drinking water for 44 d |
Immunized on day 15 and challenged on day 22 with keyhole limpet hemocyanin (KLH)
|
Vidal et al. 2008 [157] |
Balb/c mice, 6–9 wk | 10 (C) 6x10 (PB) |
Live B. adolescentis BBMN23, B. longum BBMN68 (2x107, 2x109 or 2x1011 CFUs /kg BW) for 4 wk |
Two Bifidobacterium strains isolated from healthy centenarians in China
|
Yang et al. 2009 [162] |
Female Kunming mice, 2 mo and 20 mo | Young 20 (C) Old 20 (C) 20 (PB) |
B. bifidum (5x108 CFUs/d) for 8 wk |
|
Fu et al. 2010 [158] |
Female C57BL/6 mice, 4–6 wk | 12 (C) 2x12 (PB) |
Heat killed L. bulgaricus OLL1181 (109 CFUs/d) or L. caseri MEP222701 (109 CFUs/d) for 8–11 d starting 7 d prior to colitis induction |
|
Takamura et al. 2011 [265] |
Humans | ||||
Healthy male, 40–65 y | 10 (P) 10 (PB) |
P: unfermented milk PB: L. casei (>1011 CFUs/d) fermented milk for 4 wk |
|
Spanhaak et al. 1998 [179] |
Healthy adults, 22–50 y | 9 into (P), (PB) | P: milk PB: L. GG (2.6x108 CFUs/d) for 1 wk |
|
Pelto et al. 1998 [171] |
Healthy adults, 20–50 y | 9 (P) 10/10 (PB) |
L. GG (4x1010 CFUs/d) or L. lactis (3.4x1010 CFUs/d) for 7 d |
All subjects received attenuated Salmonella typhi oral vaccine on day 1, 3, and 5
|
Fang et al. 2000 [170] |
Healthy, 41–81 y | 27/23 (PB) | B. lactis HN019 (5x1010 CFUs/d) in low fat milk/or in lactose-hydrolysed low fat milk for 3 wk |
|
Chiang et al. 2000 [172] |
Healthy elderly, >60 y | 12 (P) 13 (PB) |
Live B. lactis HN019 (3x1011 CFUs/d) for 6 wk |
|
Arunachalam et al. 2000 [167] |
Healthy, 44–80 y | 25/27 (PB) | L. rhamnosus (5x1010 CFUs/d) in low fat milk /or in lactose-hydrolysed low fat milk for 3 wk |
|
Sheih et al. 2001 [173] |
Healthy elderly, 60–84 y | 27 (PB) | L. rhamnosus HN001 (5x1010 CFUs/d) or B. lactis HN019 (5x109 CFUs/d) for 3 wk |
|
Gill et al. 2001 [168] |
Healthy elderly, 64–84 y | 29 (PB) | B. lactis HN019 (low dose, 5x109 CFUs/d or typical dose, 5x1010 CFUs/d) for 3 wk |
|
Gill et al. 2001 [169] |
Healthy adults, 51–58 y | 22 (P) 23 (PB) |
L. casei DN114001 for 8 wk |
|
Parra et al. 2004 [174] |
Healthy adults, 18–62 y | 20 (P) 7x9 (PB) |
B. lactis Bi-07, B. lactis Bl-04, L. acidophilus La-14, L. acidophilus NCFM®, L. plantarum Lp-115, L. salivarius Ls-33, L. paracasei Lpc-37; Each group received one of 7 different strains (1010 CFU/d) for 3 wk |
|
Paineau et al. 2008 [266] |
Healthy adults, 23–58 y | 16 (P) 13/16/17 (PB) |
L. rhamnosus GG (1.6x1010 CFUs/d), B. animalis ssp. Lactis Bb12 (3.5x1010 CFUs/d), P. freudenreichii ssp. Shermanii JS (3.3x1010 CFUs/d) for 3 wk |
|
Kekkonen et al. 2008 [178] |
Nursing home elderly, mean age 84.3±0.98 y | 86 (C) 67 (P) 56 (PB) |
C: commercial fermented oat drink containing B. animalis ssp lactis Bb-12 (109 CFUs/d) P: oat-based drink PB: oat-based drink with B longum 2C and 46 (109 CFUs/d, each) for 6 mo |
|
Ouwehand et al. 2008 [267] |
Elderly, regularly using non-steroidal anti-inflammatory drugs, >65 y | 23 (P) 24 (PB) |
L. acidophilus (≥1010 CFUs/d) + lactitol for 2 wk |
|
Ouwehand et al. 2009 [268] |
Healthy nursing home elderly, >70 y | 44 (P) 42 (PB) 113 (P) 109 (PB) |
P: non-fermented control dairy product for 7 wk or 13 wk PB:L. casei DN-114 001 (≥2x1010 CFUs/d) + S. thermophilus and L. bulgaricus (≥2x1010 CFUs/d) as fermented dairy drink (Actimel®) for 7 wk or 13 wk |
|
Boge et al. 2009 [176] |
Healthy elderly, 61–94 y | 13 SNH (PB) 23 SPH (PB) |
PB: L. johnsonii La1 (109 CFUs/d) in yoghurts for 4 wk |
|
Schiffrin et al. 2009 [269] |
(C) control, (P) placebo, (PB) probiotic supplementation, (S) symbiotic supplementation, SNH: subjects with negative hydrogen breath test, SPH: subjects with positive hydrogen breath test